These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37262073)

  • 1. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
    You L; Chen J; Cheng Y; Li Y; Chen YQ; Ying T; Turtle L; Yu H
    PLoS Pathog; 2023 Jun; 19(6):e1011420. PubMed ID: 37262073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups.
    Volle R; Luo L; Razafindratsimandresy R; Sadeuh-Mba SA; Gouandjika-Valisache I; Horwood P; Duong V; Buchy P; Joffret ML; Huang Z; Duizer E; Martin J; Chakrabarti LA; Dussart P; Jouvenet N; Delpeyroux F; Bessaud M
    J Gen Virol; 2023 Nov; 104(11):. PubMed ID: 37909282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients.
    Aw-Yong KL; Sam IC; Koh MT; Chan YF
    PLoS One; 2016; 11(11):e0165659. PubMed ID: 27806091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
    Huang KA; Huang PN; Huang YC; Yang SL; Tsao KC; Chiu CH; Shih SR; Lin TY
    PLoS Pathog; 2020 Sep; 16(9):e1008857. PubMed ID: 32936838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
    Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Neutralizing Antibody Response Kinetics in Patients with Hand, Foot, and Mouth Disease Caused by Coxsackievirus A16 or Enterovirus A71: A Longitudinal Cohort Study of Chinese Children, 2017-2019.
    Zhou Y; Zhou J; Yang J; Qiu Q; Wang L; Yang J; Li Y; Liang L; Cui P; Cheng Y; Zheng W; Shi H; Gong H; Wang K; Zhou C; Chu JJH; Yu H
    J Immunol; 2022 Jul; 209(2):280-287. PubMed ID: 35777850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the neutralising antibody response in patients with hand, foot, and mouth disease caused by EV-A71: A longitudinal cohort study in Zhengzhou during 2017-2019.
    Qiu Q; Zhou J; Cheng Y; Zhou Y; Liang L; Cui P; Xue Y; Wang L; Wang K; Wang H; Li P; Chen J; Li Y; Turtle L; Yu H
    EBioMedicine; 2021 Jun; 68():103398. PubMed ID: 34049245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
    Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71.
    Chen Z; Bao L; Zhu B; Fu H; Zhu S; Ji T; Xue Y; Liu C; Wang X; Li F; Lv Q; Qi F; Yu P; Deng W; Xu W; Qin C; Liu H; Jin Q
    Sci China Life Sci; 2022 Dec; 65(12):2517-2526. PubMed ID: 35696017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
    Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
    Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of different specimens in detecting enterovirus A71 in children with hand, foot and mouth disease.
    Zhou Y; Zhou C; Wang K; Qiu Q; Cheng Y; Li Y; Cui P; Liang L; Li P; Deng X; Wang L; Zheng W; Gong H; Wang F; Xu M; Chu JJH; Turtle L; Yu H
    Virol Sin; 2023 Apr; 38(2):268-275. PubMed ID: 36371008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Epidemiology and Phylodynamic Analysis of Enterovirus A71 Reveal Its Transmission Dynamics in Asia.
    Xiao J; Huang K; Lu H; Song Y; Han Z; Zhang M; Li J; Zhou X; Chen J; Yu Q; Yang M; Yan D; Ji T; Yang Q; Zhu S; Xu W; Zhang Y
    Microbiol Spectr; 2022 Oct; 10(5):e0195822. PubMed ID: 36200890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I Interferon-Induced TMEM106A Blocks Attachment of EV-A71 Virus by Interacting With the Membrane Protein SCARB2.
    Guo X; Zeng S; Ji X; Meng X; Lei N; Yang H; Mu X
    Front Immunol; 2022; 13():817835. PubMed ID: 35359978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing Antibodies against Enteroviruses in Patients with Hand, Foot and Mouth Disease.
    Nguyet LA; Thanh TT; Nhan LNT; Hong NTT; Nhu LNT; Van HMT; Ny NTH; Anh NT; Han DDK; Tuan HM; Huy VQ; Viet HL; Cuong HQ; Thao NTT; Viet DC; Khanh TH; Thwaites L; Clapham H; Hung NT; Chau NVV; Thwaites G; Ha DQ; van Doorn HR; Tan LV
    Emerg Infect Dis; 2020 Feb; 26(2):298-306. PubMed ID: 31961293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence of Enterovirus A71 Fluctuates Depending on the Phylogenetic Clade Formed in the Epidemic Year and Epidemic Region.
    Kobayashi K; Nishimura H; Mizuta K; Nishizawa T; Chu ST; Ichimura H; Koike S
    J Virol; 2021 Nov; 95(23):e0151521. PubMed ID: 34523967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the diagnostic performance and its associated factors of a commercial anti-EV-A71 IgM-capture ELISA kit in hospitalized children with clinical diagnostic HFMD.
    Zhang T; Cheng Y; Li Y; Yang J; Liang L; Yang J; Cui P; Song C; Zhou Y; Kang D; Qiu Q; Cui N; Guo C; Jing Y; Zeng M; Liu Q; Long L; Zhou C; Yu H
    J Clin Virol; 2020 Sep; 130():104582. PubMed ID: 32795960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of EV-A71 neutralizing antibodies following the 2011 epidemic in HCMC, Vietnam.
    Kuo FL; Khanh TH; Chung WY; Hung NT; Luo ST; Chang WC; Nhan LNT; Thinh LQ; Lee MS
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008124. PubMed ID: 32126083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cordycepin Inhibits Enterovirus A71 Replication and Protects Host Cell from Virus-Induced Cytotoxicity through Adenosine Action Pathway.
    Lee YP; Yu CK; Wong TW; Chen LC; Huang BM
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.